AKUMS DRUGS & PHARMACEUTICALS
Back to Cashflow Statement
|
AKUMS DRUGS & PHARMACEUTICALS Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹34 Cr | ₹73 Cr | ₹-108 Cr | ₹125 Cr | ₹236 Cr |
What is the latest Cash Flow from Financing Activities ratio of AKUMS DRUGS & PHARMACEUTICALS ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2026 | ₹34 Cr |
| Mar2025 | ₹73 Cr |
| Mar2024 | ₹-108 Cr |
| Mar2023 | ₹125 Cr |
| Mar2022 | ₹236 Cr |
How is Cash Flow from Financing Activities of AKUMS DRUGS & PHARMACEUTICALS Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹34 Cr | -53.45 | |
| Mar2025 | ₹73 Cr | Positive | |
| Mar2024 | ₹-108 Cr | Negative | |
| Mar2023 | ₹125 Cr | -47.24 | |
| Mar2022 | ₹236 Cr | - | |
Compare Cash Flow from Financing Activities of peers of AKUMS DRUGS & PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AKUMS DRUGS & PHARMACEUTICALS | ₹12,876.1 Cr | 4.4% | 9.8% | 73.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹444,597.0 Cr | 1% | -3.3% | 13.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹255,195.0 Cr | 2.6% | 10.8% | 57.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹187,712.0 Cr | 2.7% | 0.3% | 39.6% | Stock Analytics | |
| CIPLA | ₹113,423.0 Cr | 2.4% | -1.1% | -12.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,195.0 Cr | 2.5% | 0.8% | -8.5% | Stock Analytics | |
AKUMS DRUGS & PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AKUMS DRUGS & PHARMACEUTICALS | 4.4% |
9.8% |
73.3% |
| SENSEX | -1% |
-4.9% |
-11% |
You may also like the below Video Courses